| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/23/2009 | CN101607044A Method for curing head-eye vertigo by taking foot bath in traditional Chinese medicine solution |
| 12/23/2009 | CN101607043A Method for treating externally infected wind-cold and vertigo symptoms by soaking feet into Chinese medicament |
| 12/23/2009 | CN101607026A New six-ingredient rehmannia pill |
| 12/23/2009 | CN101607019A Medicine used for treating stomachache |
| 12/23/2009 | CN101607011A Traditional Chinese medicine for treating cholecystitis post-operative complacation |
| 12/23/2009 | CN101607002A Traditional Chinese medicine health-care and nutritious wine |
| 12/23/2009 | CN101606998A Inflammation-diminishing analgesia liquid of dental diseases |
| 12/23/2009 | CN101606997A Medicine for treating toothache and preparation method thereof |
| 12/23/2009 | CN101606984A Traditional Chinese medicine for treating hepatopathy |
| 12/23/2009 | CN101606977A Preparation method and application of clove leaf total iridoid glycoside |
| 12/23/2009 | CN101606976A Method for preparing tetrandrine alkaloids by coupling in-situ conversion-adsorptive separation technology |
| 12/23/2009 | CN101606974A Pharmaceutical composition for treating acute and chronic hepatitis |
| 12/23/2009 | CN101606966A Medicament for curing hepatitis B and other hepatitis |
| 12/23/2009 | CN101606965A Fat-reducing liver-protecting tea and preparation method thereof |
| 12/23/2009 | CN101606964A Veterinary traditional Chinese medical compound preparation |
| 12/23/2009 | CN101606962A Sugarless south isatis root granules and preparation method thereof |
| 12/23/2009 | CN101606960A Oral medicinal composition |
| 12/23/2009 | CN101606951A Thick-shell mussel fat-soluble extract, preparation method and application thereof |
| 12/23/2009 | CN101606941A Injection liquid for treating nocardia seriolae infection of dog and preparation method thereof |
| 12/23/2009 | CN101606906A Ursodeoxycholic acid nano suspension and preparation method thereof |
| 12/23/2009 | CN101606695A Natural liver-nourishing, toxin-expelling and cholesterol-lowering porridge and preparation method |
| 12/23/2009 | CN100573139C Method for detecting content of paeoniflorin, psoralen and isopsoralen in pill for strengthening spleen and intestines |
| 12/23/2009 | CN100572380C Berberine ion pair compound, preparing method and drug containing same |
| 12/23/2009 | CN100571769C Granule of zhamusa-four-does and its preparation method |
| 12/23/2009 | CN100571768C Pharmaceutical composition, its preparation and usage |
| 12/23/2009 | CN100571761C Traditional Chinese medicine composition for treating hepatopathy and method of preparing the same |
| 12/23/2009 | CN100571760C Prescription of mouth ulcer bilayer film and technique of preparing the same |
| 12/23/2009 | CN100571733C Health medicinal beverage vinegar and method of preparing the same |
| 12/23/2009 | CN100571727C Compound recipe gallstone direct dissolution agent and its preparing process |
| 12/23/2009 | CN100571721C Extract of Kadsura longepedunculata Finet et Gagnep, preparation process and use thereof |
| 12/23/2009 | CN100571720C Medicine for treating hepatic fibrosis and preparation process thereof |
| 12/23/2009 | CN100571715C Compositions containing bioactive materials, methods of preparation and treatment |
| 12/23/2009 | CN100571694C Mesalazine colon target releasing micro pills and preparation method thereof |
| 12/23/2009 | CN100571680C Preparation method of compound bitter sophora preparation for injection and medical use thereof |
| 12/23/2009 | CN100571546C Methods of using a beverage composition |
| 12/23/2009 | CN100571523C Health care tea for improving function of gstrointestinal tract, and preparation method |
| 12/23/2009 | CA2727914A1 Spirodiamine-diaryl ketoxime derivative technical field |
| 12/23/2009 | CA2727147A1 Glycosylated glp-1 peptide |
| 12/23/2009 | CA2725657A1 Novel heteroaryl carboxamide derivatives |
| 12/23/2009 | CA2724449A1 5-ht3 receptor modulators, methods of making, and use thereof |
| 12/23/2009 | CA2670211A1 Teeth bleaching compositions and devices |
| 12/22/2009 | US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide |
| 12/22/2009 | US7635774 Benzimidazole derivatives |
| 12/22/2009 | US7635751 For development of pharmaceutical preparations such as neutral nerve function regulator, circulatory function regulator, a cardiac function regulator, an immune function regulator, a digestive organ function regulator, metabolic function regulator |
| 12/22/2009 | US7635714 treating constipation in a patient with 8,9-didehydro-N-demethyl-9-deoxo-6,11-dideoxy-6,9-epoxy-12-O-methyl-N-(1-methylethyl)-11-oxoerythromycin; unlike a laxative |
| 12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
| 12/22/2009 | CA2415214C Phosphotetrahydropyran compounds |
| 12/22/2009 | CA2414514C Carbamates derived from arylalkylamines |
| 12/22/2009 | CA2413026C Cold water soluble .beta.-glucan product and process for preparing the same |
| 12/22/2009 | CA2405593C Macrolides |
| 12/22/2009 | CA2387973C Pharmaceutical formulation containing tolterodine and its use |
| 12/22/2009 | CA2373909C Multilayer drug form release in the colon |
| 12/22/2009 | CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/22/2009 | CA2346847C Novel imidazoles with anti-inflammatory activity |
| 12/22/2009 | CA2326529C 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide |
| 12/22/2009 | CA2234565C Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 12/22/2009 | CA2173839C Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/22/2009 | CA2114221C 1, 3-oxathiolane nucleoside analogues |
| 12/19/2009 | CA2636864A1 Method, composition, and device, for the treatment of amylase activity malfunctions / inactivity in association with saccharides (mainly polysaccharides) based diseases |
| 12/17/2009 | WO2009152089A2 Prebiotic composition and methods of making and using the same |
| 12/17/2009 | WO2009151626A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists |
| 12/17/2009 | WO2009151621A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists |
| 12/17/2009 | WO2009151456A1 Thiazole compounds, and compositions and methods using same |
| 12/17/2009 | WO2009151330A1 Nutritional composition for infants delivered via caesarean section |
| 12/17/2009 | WO2009151315A1 Nutritional composition for infants delivered via caesarean section |
| 12/17/2009 | WO2009151125A1 Diagnosis and treatment of hepatic disorder |
| 12/17/2009 | WO2009151116A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/17/2009 | WO2009151020A1 Novel fermented milk product and use thereof |
| 12/17/2009 | WO2009150888A1 Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent |
| 12/17/2009 | WO2009150036A1 Method for decreasing borborygmi by administering a bifidobacterium bacteria. |
| 12/17/2009 | WO2009149795A2 Heterocyclic cyclopropyl-substituted fxr binding compounds |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312425 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 12/17/2009 | US20090312358 Method for management of diarrhea |
| 12/17/2009 | US20090312357 Rifaximin |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/17/2009 | US20090312307 Heterocyclo inhibitors of potassium channel function |
| 12/17/2009 | US20090312302 Compositions and methods for treating nonalcoholic fatty liver disease-associated disorders |
| 12/17/2009 | US20090312260 Drug therapy for celiac sprue |
| 12/17/2009 | US20090312259 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 12/17/2009 | US20090312258 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312243 Treatment of inflammatory bowel disease (ibd) with anti-angiogenic compounds |
| 12/17/2009 | US20090311746 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311201 Lipoxin analogs and methods for the treatment of periodontal disease |
| 12/17/2009 | US20090311199 Use of Hydrogen Peroxide-Producing Bacteria for Tooth Whitening |
| 12/17/2009 | CA2727595A1 Thiazole compounds, and compositions and methods using same |
| 12/17/2009 | CA2727462A1 Use of hydrogen peroxide-producing bacteria for tooth whitening |
| 12/17/2009 | CA2726560A1 Dual-phase mouth wash composition |
| 12/16/2009 | EP2133353A1 Novel adenine compound |
| 12/16/2009 | EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 12/16/2009 | EP2133121A1 Nutritional additives containing cranberry extract for the digestive system and their uses |
| 12/16/2009 | EP2133083A1 Therapeutic agent for infectious skin or mucosal disease |
| 12/16/2009 | EP2132175A2 Process for the preparation of loperamide |
| 12/16/2009 | EP2131829A1 Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants |
| 12/16/2009 | EP2131823A2 Rapid-disintegration monolayer film for the oral administration of active substances |
| 12/16/2009 | EP2131670A1 Sweetener-containing animal food and animal food additives |